150 likes | 277 Views
Daily Temozolomide Following Failure of Prior RT + TMZ for GBM: Update on the RESCUE Study J. Perry, W. Mason, K. Belanger, P. Kavan, D. Fulton, J. Easaw, S. Kirby, D. MacDonald, C. Shields and J.-F. Pouliot.
E N D
Daily Temozolomide Following Failure of Prior RT + TMZ for GBM: Update on the RESCUE Study J. Perry, W. Mason, K. Belanger, P. Kavan, D. Fulton, J. Easaw, S. Kirby, D. MacDonald, C. Shields and J.-F. Pouliot
42-year-old woman with GBM treated with daily temozolomide at first relapse on the NCIC-CTG/EORTC Trial CR after 4 cycles continuous TMZ 50 mg/m2 PD: 9 mo after RT/TMZ, 6 cycles adjuvant TMZ
Non hematological Toxicity (worst grade) *All AEs irrespective of causality incidence >2% No Grade 4 toxicity reported at this point in time